参考文献/References:
[1] Li J,Liu WD,Yang ZL,et al.Prevalence and spectrum of GATA4 mutations associated with sporadic dilated cardiomyopathy[J].Gene,2014,548(2):174-181.
[2] Matsa LS,Sagurthi SR,Ananthapur V,et al.Endothelin 1 gene as a modifier in dilated cardiomyopathy[J].Gene,2014,548(2):256-262.
[3] Garcia-Pavia P,Cobo-Marcos M,Guzzo-Merello G,et al.Genetics in dilated cardiomyopathy[J].Biomark Med,2013,7(4):517-533.
[4] Lakdawala NK,Winterfield JR,Funke BH.Dilated cardiomyopathy[J].Circ Arrhythm Electrophysiol,2013,6(1):228-237.
[5] Pennell DJ.Cardiovascular magnetic resonance[J].Circulation,2010,121(5):692-705.
[6] Berk F,Isgoren S,Demir H,et al.Assessment of left ventricular function and volumes for patients with dilated cardiomyopathy using gated myocardial perfusion SPECT and comparison with echocardiography[J].Nucl Med Commun,2005,26(8):701-710.
[7] Matsuo S,Nakae I,Tsutamoto T,et al.A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies[J].J Nucl Cardiol,2007,14(2):215-220.
[8] Gulati A,Jabbour A,Ismail TF,et al.Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J].JAMA,2013,309(9):896-908.
[9] Wang L,Yan C,Zhao S,et al.Comparison of(99m)Tc-MIBI SPECT/18f-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy:assessment of cardiac function and myocardial injury[J].Clin Nucl Med,2012,37(12):1163-1169.
[10] Gao P,Yee R,Gula L,et al.Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator:evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging[J].Circ Cardiovasc Imaging,2012,5(4):448-456.
[11] Gulati A,Jabbour A,Ismail TF,et al.Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J].JAMA,2013,309(9):896-908.
[12] Shi HW,Pu P,Deng W,et al.Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients. A meta-analysis[J].Saudi Med J,2013,34(7):719-726.
[13] Stork A,Mullerleile K,Bansmann PM,et al.Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies[J].Rofo,2007,179(1):21-30.
[14] Gao P,Yee R,Gula L,et al.Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator:evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging[J].Circ Cardiovasc Imaging,2012,5(4):448-456.
[15] Shimizu I,Iguchi N,Watanabe H,et al.Delayed enhancement cardiovascular magnetic resonance as a novel technique to predict cardiac events in dilated cardiomyopathy patients[J].Int J Cardiol,2010,142(3):224-229.
[16] Alter P,Rupp H,Adams P,et al.Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy[J].Eur J Heart Fail,2011,13(9):937-944.
[17] Moraes GL,Higgins CB,Ordovas KG.Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease[J].J Thorac Imaging,2013,28(2):84-92; quiz 93-95.
[18] Friedrich MG.There is more than shape and function[J].J Am Coll Cardiol,2008,52(19):1581-1583.
[19] Kramer CM,Narula J.Viability is in the eye of the beholder[J].JACC Cardiovasc Imaging,2012,5(5):574-575.
[20] Lee JJ,Liu S,Nacif MS,et al.Myocardial T1 and extracellular volume fraction mapping at 3 tesla[J].J Cardiovasc Magn Reson,2011,13:75.
[21] Sibley CT,Noureldin RA,Gai N,et al.T1 mapping in cardiomyopathy at cardiac MR:comparison with endomyocardial biopsy[J].Radiology,2012,265(3):724-732.
[22] Puntmann VO,Voigt T,Chen Z,et al.Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy[J].JACC Cardiovasc Imaging,2013,6(4):475-484.
[23] Dass S,Suttie JJ,Piechnik SK,et al.Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy[J].Circ Cardiovasc Imaging,2012,5(6):726-733.
[24] Hwang SH,Choi BW.Advanced cardiac MR imaging for myocardial characterization and quantification:T1 mapping[J].Korean Circ J,2013,43(1):1-6.
[25] Jellis C,Martin J,Narula J,et al.Assessment of nonischemic myocardial fibrosis[J].J Am Coll Cardiol,2010,56(2):89-97.
[26] Kramer CM,Chandrashekhar Y,Narula J.T1 mapping by CMR in cardiomyopathy: a noninvasive myocardial biopsy?[J].JACC Cardiovasc Imaging,2013,6(4):532-534.
[27] Ugander M,Oki AJ,Hsu LY,et al.Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology[J].Eur Heart J,2012,33(10):1268-1278.
[28] Sado DM,Flett AS,Banypersad SM,et al.Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease[J].Heart,2012,98(19):1436-1441.
[29] Chen Z,Sohal M,Voigt T,et al.Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators[J].Heart Rhythm,2015,12(4):792-801.
[30] Li W,Lu M,Banerjee S,et al.Ex vivo diffusion tensor MRI reflects microscopic structural remodeling associated with aging and disease progression in normal and cardiomyopathic Syrian hamsters[J].NMR Biomed,2009,22(8):819-825.
相似文献/References:
[1]吴琼,杨爱玲,周端,等.扩张型心肌病左室逆重构的研究进展[J].心血管病学进展,2019,(6):885.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.012]
WU Qiong,YANG Ailing,ZHOU Duan,et al.Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(1):885.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.012]
[2]刘超 曲杰 王明娟 徐倩 范彦芳 周晓慧 单伟超.肺动脉高压对扩张型心肌病预后的影响[J].心血管病学进展,2020,(4):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
LIU ChaoQU JieWANG MingjuanXU QianFAN YanfangZHOU XiaohuiSAN Weichao.The Effect of Pulmonary Hypertension on the Prognosis of Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(1):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
[3]梁科研 杨芳 褚静洁.四维超声心动图评价扩张型心肌病右心室整体收缩功能及其临床意义[J].心血管病学进展,2020,(5):547.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.025]
LIANG Keyan,YANG Fang,CHU Jingjie.Four-dimensional Echocardiography for Evaluation of Right Ventricular Systolic Function in Dilated Cardiomyopathy and Its Clinical Significance[J].Advances in Cardiovascular Diseases,2020,(1):547.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.025]
[4]宋元秀 崔鸣.线粒体动力学异常与相关心血管疾病[J].心血管病学进展,2021,(2):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
SONG Yuanxiu,CUI Ming.Correlation Between Mitochondrial Dynamics and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2021,(1):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[5]唐毅 唐艺金 黄培 杨小燕 张翼 彭建强 郑昭芬 王银珍.人附睾蛋白4对扩张型心肌病患者短期预后评估的价值[J].心血管病学进展,2021,(11):1052.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
TANG Yi,TANG Yijin,HANG Pei,et al.The Value of Human Epididymal Protein 4 in Assessment of Short-Term Prognosis of Patients with Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(1):1052.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]